Eledon Pharmaceuticals, Inc.

Biotechnology • Healthcare • Irvine, CA, United States • ELDN (NCM)

Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It uses its immunology expertise in targeting the CD40 Ligand (CD40L) pathway to develop therapies to protect transplanted organs and prevent rejection, and to treat amyotrophic lateral sclerosis (ALS). The company's lead compound in development is tegoprubart, an IgG1 and anti-CD40L antibody with high affinity for CD40 Ligand, a biological target with therapeutic potential. It is also developing its products for the prevention of allograft rejection in kidney transplantation and xenotransplantation. The company has a collaboration agreement with eGenesis, Inc. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.

Stock Performance (90 Days)

Data through Dec 23, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Receives Average Rating of "Hold" from Analysts - MarketBeat

MarketBeat • Dec 17

Eledon Pharmaceuticals Announces Pricing of $50 Million - GlobeNewswire

GlobeNewswire • Nov 12

Eledon Pharmaceuticals Restructures Stake via Pre-Funded Warrant - TipRanks

TipRanks • Jan 2

Eledon Pharmaceuticals stock rises after positive islet transplant data - Investing.com

Investing.com • Nov 18

Assessing Eledon Pharmaceuticals (ELDN) Valuation After Phase 2 Kidney Transplant Trial Results and Phase 3 Prospects - Yahoo Finance

Yahoo Finance • Nov 9

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Eledon Pharmaceuticals, Inc. had layoffs?

No layoff events have been recorded for Eledon Pharmaceuticals, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Eledon Pharmaceuticals, Inc. have?

Eledon Pharmaceuticals, Inc. has approximately 31 employees.

What industry is Eledon Pharmaceuticals, Inc. in?

Eledon Pharmaceuticals, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Eledon Pharmaceuticals, Inc. a publicly traded company?

Yes, Eledon Pharmaceuticals, Inc. is publicly traded under the ticker symbol ELDN on the NCM. The company has a market capitalization of approximately $0.11 billion.

Where is Eledon Pharmaceuticals, Inc. headquartered?

Eledon Pharmaceuticals, Inc. is headquartered in Irvine, CA, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.